What Is the Test
The Oncotype DX test reveals the underlying tumour biology to help guide treatment decisions.
The Oncotype DX test should be used when the benefit of chemotherapy for a patient is uncertain.
Latest TAILORx Data
After 5 years, 99% of women with a low Oncotype DX Breast Recurrence Score (<11) were recurrence-free with hormone therapy alone.
Visit these pages for further information on the Oncotype DX test and FAQs.